– Company to Use its Cash on Hand to Operate its Business During the Proceedings and Continues to Serve Customers and Patients – SAN FRANCISCO, Feb. 13, 2024 /PRNewswire/ — Invitae (OTC: NVTA), a leading medical genetics company, announced today that it is building on previous actions to…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.